Non-alcoholic fatty liver disease (NAFLD)
Conditions
Interventions
Experimental group:Sijunzi Tang Granules
Sponsors
Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. Those who signed the informed consent; 2. Aged 18-65 years, gender is not limited; 3. Those who meet the diagnostic criteria of NAFLD in traditional Chinese and Western medicine.
Exclusion criteria
Exclusion criteria: 1. Combined with drug-induced liver injury, autoimmune hepatitis A, B, C, E, etc.; 2. Patients with serious primary diseases of the heart, brain, kidney, lung, endocrine, blood, metabolism and gastrointestinal tract, or mental patients; 3. Creatinine (Cr) is greater than the upper limit of normal; 4. Those who use drugs to lose weight; 5. Alcoholics or drug addicts; 6. Pregnant patients, lactating patients or those who are planning to become pregnant in the near future and those who use estrogen contraception; 7. Allergic constitution and allergic to various drugs, as well as this medicine or the components of this prescription; 8. Those who are in critical condition and it is difficult to make an exact evaluation of the effectiveness and safety of new drugs; 9. The patient is reluctant to collaborate.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| microRNA;alanine aminotransferase;aspartate aminotransferase;triglycerides;cholesterol;fasting blood sugar; | — |
Countries
China
Contacts
Public ContactYu Xiao
Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Outcome results
None listed